Stella Pharma Corp. Hits Day High with 16.53% Surge in Stock Price

Stella Pharma Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant movement in its stock today, gaining 16.53% as of March 23, 2026. The stock reached an intraday high of JPY 705.00, marking a notable achievement amidst a challenging market environment, as the Japan Nikkei 225 index declined by 3.48% on the same day. Over the past week, Stella Pharma has shown remarkable resilience, with a performance increase of 70.29%, and a striking 78.03% rise over the past month. Year-to-date, the stock has surged by an impressive 247.29%, significantly outperforming the broader market index, which has only seen a 2.34% increase. Despite these gains, the company faces challenges, including a negative return on equity and a concerning trend in operating profit growth. The stock's performance metrics indicate a complex financial landscape, with a market capitalization of JPY 8,066 million and a price-to-book ratio of 2.78. Investors should consider these factors as they assess the company's position in the market.